MyFinsight
Home
Blog
About
Marketable securities
$64,137K
(-23.77%↓ Y/Y)
Cash and cash
equivalents
$5,541K
(-27.93%↓ Y/Y)
Prepaid expenses and
other current assets
$1,673K
(-49.56%↓ Y/Y)
Restricted cash
$254K
(69.33%↑ Y/Y)
Property, plant and
equipment, net
$111,778K
(74418.67%↑ Y/Y)
Total current assets
$71,605K
(-65.47%↓ Y/Y)
Accrued rent receivable
$8,271K
Other long-term
assets
$3,909K
(-65.10%↓ Y/Y)
Operating lease
right-of-use assets
$2,149K
(264.24%↑ Y/Y)
Total assets
$197,712K
(-14.41%↓ Y/Y)
Total liabilities and
stockholders equity
$197,712K
(-14.41%↓ Y/Y)
Total stockholders
equity
$107,380K
(-18.45%↓ Y/Y)
Total liabilities
$90,332K
(-9.05%↓ Y/Y)
Accumulated deficit
-$734,991K
(-4.30%↓ Y/Y)
Accumulated other
comprehensive loss
-$587K
(27.08%↑ Y/Y)
Additional paid-in capital
$842,958K
(0.69%↑ Y/Y)
Loan payable
$85,192K
(0.91%↑ Y/Y)
Total current
liabilities
$3,305K
(-76.14%↓ Y/Y)
Operating lease
liabilities, non-current
$1,835K
(30483.33%↑ Y/Y)
Accrued expenses and
other current...
$2,510K
(-81.17%↓ Y/Y)
Accounts payable
$795K
(52.01%↑ Y/Y)
Back
Back
Balance Sheet
Instil Bio, Inc. (TIL)
Instil Bio, Inc. (TIL)
source: myfinsight.com